Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Berry

Showing results (291-300 of 312) with videos related to

Pageof 32
Sort By:
Neurology|December 28, 2012
New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPANPenelope Hogarth, Allison Gregory, Michael C Kruer, et al.
Cell Reports|April 14, 2021
Cell-type-specific profiling of human cellular models of fragile X syndrome reveal PI3K-dependent defects in translation and neurogenesisNisha Raj, Zachary T McEachin, William Harousseau, et al.
Science Translational Medicine|December 1, 2021
The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type CJohn V Pluvinage, Jerry Sun, Christel Claes, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 16, 2025
Genome Sequencing Uncovers Additional Findings in Phelan-McDermid SyndromeRachel Gore Moses, Morgan Similuk, Alexandra Hehn, et al.
Science Translational Medicine|January 7, 2011
Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056Sébastien Jacquemont, Aurore Curie, Vincent des Portes, et al.
Neurogenetics|February 8, 2013
MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathwaysAlex R Paciorkowski, Ryan N Traylor, Jill A Rosenfeld, et al.
Molecular Genetics and Metabolism Reports|June 16, 2025
Efficacy results from a 12-month double-blind randomized trial of arimoclomol for treatment of Niemann-Pick disease type C (NPC): Presenting a rescored 4-domain NPC Clinical Severity ScaleEugen Mengel, Marc C Patterson, Rosalia M Da Riol, et al.
Journal of the American Academy of Dermatology|January 19, 2025
Development of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excisionJaclyn N Roland-McGowan, Steven Caleb Freeman, Wenelia Baghoomian, et al.
The Journal of Clinical Investigation|August 31, 2023
Effects of AFQ056 on language learning in fragile X syndromeElizabeth Berry-Kravis, Leonard Abbeduto, Randi Hagerman, et al.
Frontiers in Psychiatry|June 29, 2026
A naturalistic, non-invasive method for capturing biometric data during autism evaluationsKhaleel Kamal, Janka Hatvani, Máté Pethő, et al.
Pageof 32

Showing results (291-300 of 312) with videos related to

Sort By:
Pageof 32
Neurology|December 28, 2012
New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPANPenelope Hogarth, Allison Gregory, Michael C Kruer, et al.
Cell Reports|April 14, 2021
Cell-type-specific profiling of human cellular models of fragile X syndrome reveal PI3K-dependent defects in translation and neurogenesisNisha Raj, Zachary T McEachin, William Harousseau, et al.
Science Translational Medicine|December 1, 2021
The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type CJohn V Pluvinage, Jerry Sun, Christel Claes, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 16, 2025
Genome Sequencing Uncovers Additional Findings in Phelan-McDermid SyndromeRachel Gore Moses, Morgan Similuk, Alexandra Hehn, et al.
Science Translational Medicine|January 7, 2011
Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056Sébastien Jacquemont, Aurore Curie, Vincent des Portes, et al.
Neurogenetics|February 8, 2013
MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathwaysAlex R Paciorkowski, Ryan N Traylor, Jill A Rosenfeld, et al.
Molecular Genetics and Metabolism Reports|June 16, 2025
Efficacy results from a 12-month double-blind randomized trial of arimoclomol for treatment of Niemann-Pick disease type C (NPC): Presenting a rescored 4-domain NPC Clinical Severity ScaleEugen Mengel, Marc C Patterson, Rosalia M Da Riol, et al.
Journal of the American Academy of Dermatology|January 19, 2025
Development of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excisionJaclyn N Roland-McGowan, Steven Caleb Freeman, Wenelia Baghoomian, et al.
The Journal of Clinical Investigation|August 31, 2023
Effects of AFQ056 on language learning in fragile X syndromeElizabeth Berry-Kravis, Leonard Abbeduto, Randi Hagerman, et al.
Frontiers in Psychiatry|June 29, 2026
A naturalistic, non-invasive method for capturing biometric data during autism evaluationsKhaleel Kamal, Janka Hatvani, Máté Pethő, et al.
Pageof 32